Clinical Trial Update: Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a Phase 2/Phase 3 trial of iloprost for pulmonary hypertension due to pulmonary fibrosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis
• Pulmonary Hypertension

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: Interstitial Lung Disease Study Group, Korea | Conditions: Pulmonary Fibrosis, Pulmonary Hypertension | Phase 2, Phase 3 | Status: UNKNOWN